AbbVie Inc recalls CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000
See all recalls from AbbVie Inc →Recalled Product
CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Hazard / Issue
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
Issued by
FDA
Distribution: Nationwide (United States)
Lot/Code Info: Lot #: 1020156; Expiry: 3/31/2016
✅ What Should You Do?
- 1Stop taking this medication and contact your doctor or pharmacist immediately.
- 2Do NOT flush medications down the drain — use an FDA-approved drug take-back program.
- 3Check the lot number on your bottle or packaging against the recalled lots listed above.
- 4Report adverse events to FDA MedWatch or call 1-800-FDA-1088.
Looking for a safe alternative?
Search Amazon for CREON (pancrelipase) Delayed-Release Capsules, →If you were harmed by this recalled product, Top Class Actions lists active class action lawsuits and settlements that may apply to you.
Get the next US recall alert before it hits the news.
Free. Weekly digest or instant alerts. Unsubscribe anytime.
CAN-SPAM compliant · No spam · Unsubscribe anytime